MassDevice

Haemonetics wins expanded FDA nod for vascular closure system in PFA, LAAC to treat AFib

Haemonetics (NYSE:HAE) announced today that it received FDA approval to expand the labeling for its Vascade MVP XL system.

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug ...
Seeking Alpha

Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device

BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...
Pharmabiz

Haemonetics receives US FDA nod to expand labelling of VASCADE MVP XL venous vascular closure system

Haemonetics receives US FDA nod to expand labelling of VASCADE MVP XL venous vascular closure system: Boston Wednesday, April 1, 2026, 17:00 Hrs [IST] Haemonetics Corporation, a g ...

Haemonetics Corporation: Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP XL Venous Vascular Closure System

VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies BOSTON, March 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: ...